Form D · Pharmaceuticals
Lewis & Clark Pharmaceuticals, Inc.
Charlottesville, VA · CIK 0001562279
Offering snapshot reported Jan 25, 2016 · SEC filing
- Reported sold
- $25K Offering amount: $1.7M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jan 8, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2016 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Oct 21, 2013 | Amendment | $375,000 | $25,000vs Dec 4, 2012 | 1 | SEC filing |
| Dec 4, 2012 | Amendment | $350,000 | $300,000vs Nov 15, 2012 | 1 | SEC filing |
| Nov 15, 2012 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-255848
Source: Form D, filed Jan 25, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| C. Thomas Carter | Director |
| Thomas Carter | Director |
| Joel M. Linden | Director |
| Miette Michie | Director |
| Larry E. Rodman | Director, Executive |
| Robert D. Thompson | Director, Executive |
| Jeffrey J. Totten | Director |
| Edward J. Williams | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1180 Seminole Trail, Suite 495
Charlottesville, VA, 22901
Charlottesville, VA, 22901